Renagel

Renagel (sevelamer hydrochloride) is a phosphate binder used to manage hyperphosphatemia in chronic kidney disease patients on dialysis. This comprehensive monograph details its mechanism of action, clinical evidence, and practical use guidelines. Learn about its role in reducing cardiovascular risk and how it compares to other binders in modern nephrology practice. Let’s talk about Renagel. If you’re in nephrology, you know the name. It’s not a new drug, but its story and its place in our toolkit for managing dialysis patients is more nuanced than the monograph leaflet suggests.